Prevalence and fatality rates of COVID-19 in the elder age groups of Azerbai- jan population
Research article: Prevalence and fatality rates of COVID-19 in the elder age groups of Azerbai- jan population
Authors: U.F. Hashimova1*, A.M. Hajiyev1, Kh.M. Safikhanova1, S.I. Huseynova1, M.A. Mejidova2, N.V. Ahmedova2, G.Z. Gasimova1, F.E. Rustamov1
1Academician Abdulla Garayev Institute of Physiology, Azerbaijan National Academy of Sciences, 78 Sharif-zadeh Str., Baku AZ1100, Azerbaijan
2Baku Herontological Center, Ministry of Health of the Republic of Azerbaijan, 151a Azadlig Ave., Baku AZ1007, Azerbaijan
*For correspondence: ulduz.hashimova@physiology.science.az
Received 01 November 2020; Received in revised form 06 November 2020; Accepted 16 November 2020
Abstract:
The research aimed to study the age-related pattern of infection, and death rate among the confirmed positive cases of coronavirus (COVID-19) infection in people aged 60 and over. The statistical data on the prevalence and fatality rate of COVID-19 were provided by the Gerontological Center (Baku, Azerbaijan) and the Polyclinic of the Central Hospital in Lankaran, located in the south-eastern part of Azerbaijan. The analysis of statistical material has shown that the prevalence rate for COVID-19 is the highest for the age group of 60-75 years. It was also found that the fatality rate among the people aged 60+ with coronavirus infection was age-associated, and was the highest in the 80-89 age group. The obtained findings are consistent with the statistical data for COVID-19 prevalence and fatality rates for other countries and are indicative of a higher risk of death from coronavirus infec- tion in older people.
Keywords: COVID-19, coronavirus infection, age groups, Azerbaijan population
References
Davies N., Klepac P., Liu Y., Prem K., Jit M., CMMID COVID-19 working group and Eggo R.M. (2020) Age-dependent effects in the trans-mission and control of COVID-19 epidemics. Nature Medicine, 26: 1205–1211.
Ioannidis J., Axfors C., Contopoulos-Ioannidis D. (2020) Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying dis-eases in pandemic epicenters. Environmental Re-search, 188: 109890, doi: 10.1016/j.envres. 2020.109890
Liu Y., Mao B., Yang J.W., Lu H.-W., Chai Y.-H., Wang L., Zhang L., Li Q.-H., Zhao L., He Y., Gu X.-L., Ji X.-B., Li L., Jie Z.-J., Li Q., Li X.-Y., Lu H.-Z., Zhang W.-H., Song Y.-L., Qu J.-M., Xu J.-F., on behalf of the Shanghai Clin-ical Treatment Experts Group for COVID-19 (2020) Association between age and clinical characteristics and outcomes of COVID-19. Eur. Respir. J., 55(5): 2001112. doi: 10.1183/ 13993003.01112-2020
Omori R., Matsuyama R., Nakata Y. (2020) The age distribution of mortality from novel corona-virus disease (COVID-19) suggests no large dif-ference of susceptibility by age. Scientific Re-ports, 10(1): 16642. doi: 10.1038/s41598-020-73777-8
Perrotta F., Corbi G., Mazzeo G. (2020) COVID-19 and the elderly: insights into patho-genesis and clinical decision-making. Aging Clin. Exp. Res., 16: 1–10, doi: 10.1007/s40520-020-01631-y
Sudharsanan N., Didzun O., Barnighausen T., Geldsetzer P. (2020) The Contribution of the Age Distribution of Cases to COVID-19 Case Fa-tality across countries: A 9-country demographic study. Annals of Internal Medicine. M20-2973 https://doi.org/10.7326/M20-2973
Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., Guan L., Wei Y., Li H., Wu X., Xu J., Tu S., Zhang Y., Chan H., Cao B. (2020) Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective co-hort study. Lancet, 395: 1054–1062
https://who.int
https://koronavirusinfo.az
https://worldometers.info
